Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression
暂无分享,去创建一个
S. Naito | T. Sasada | K. Itoh | N. Komatsu | A. Yamada | S. Matsueda | T. Kakuma | Kazumasa Matsumoto | M. Noguchi | Shigetaka Suekane | Fukuko Moriya | G. Arai | S. Suekane